Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Ongoing crawled date : 2021 - 09 - 13 save search
Galecto Announces First Patient Treated in Phase 2 Trial of Oral Galectin-3 Inhibitor GB1211 in Liver CirrhosisGalecto now has three ongoing Phase 2 clinical trials with three different drug candidates in three high value indications
Published: 2021-09-13 (Crawled : 18:00) - biospace.com/
GLTO | $0.7077 4.94% 4.71% 110K
|
Health Technology
|
| O: 0.0%
H: 2.27%
C: -2.27%
gb1211 phase 2 ongoing clinical trials cirrhosis trials drug liver trial liver cirrhosis galectin-3
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval
Published: 2021-09-13 (Crawled : 12:00) - biospace.com/
RDHL | $0.4301 11.57% 10.37% 660K
|
Health Technology
|
| O: -0.74%
H: 0.45%
C: -7.98%
covid phase 2 biopharma ongoing phase 2/3 approval
Matinas BioPharma Announces Positive Data in the Ongoing EnACT Trial of MAT2203 (Oral Amphotericin B) for the Treatment of Cryptococcal Meningitis, Exceeding the Prespecified Primary Endpoint Threshold
Published: 2021-09-13 (Crawled : 11:00) - globenewswire.com
MTNB | $0.19 -1.04% 0.0% 960K
|
Health Technology
|
| O: 7.75%
H: 23.6%
C: 17.98%
treatment biopharma ongoing positive trial mat2203
TCR2 Therapeutics to Announce Extended Results from Ongoing Phase 1/2 Trial of Gavo-cel in Mesothelin-Expressing Solid Tumors
Published: 2021-09-13 (Crawled : 11:00) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: 1.71%
H: 3.42%
C: -0.27%
solid tumors ongoing phase 1 results trial phase 2 phase 3 cel
BioXcel Therapeutics to Present Updates from Ongoing Trial of BXCL701 in Aggressive Forms of Prostate Cancer at 2021 ESMO Congress
Published: 2021-09-12 (Crawled : 00:00) - globenewswire.com
BTAI | $2.56 -1.16% -1.17% 240K
|
Health Technology
|
| O: 1.32%
H: 4.96%
C: 1.78%
ongoing prostate cancer cancer trial
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.